+22.6%
CRCL vs THC
+55.7%
-33.1%
-80.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.1% | +0.6% | -1.7% | -1.3% |
| 7D | +17.1% | -0.7% | +17.8% | +17.3% |
| 30D | +61.3% | +1.3% | +60.0% | +60.6% |
| 3M | +12.7% | +64.2% | -51.5% | -0.9% |
| 6M | -3.1% | +8.3% | -11.3% | -6.7% |
| YTD | +28.7% | +33.4% | -4.7% | +17.2% |
| 1Y | -13.1% | +37.7% | -50.8% | -22.7% |
| All | +22.6% | +55.7% | -33.1% | +5.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling